What was delivered in 2020-21?
This year, we continued the spread of nationally approved innovations to our colleagues and partners in Wessex, within the context of the pandemic.
"Adam and Joe gave our clinicians significant assistance and expertise throughout this project which has just successfully concluded. Due to their hard work, HHFT Cardiac CT is in a completely different place, compared to where it would have been. This has translated into pathway improvements, better outcomes and reduction in unnecessary invasive testing for our patients, which would not have been possible without AHSN input."
- Alex Whitfield, chief executive, and Dr Lara Alloway, chief medical officer - Hampshire Hospitals NHS Foundation Trust
AHSN National Lipid Management and Familial Hypercholesterolaemia programme
Over the next three years, AHSNs will support the NHS to optimise lipid management in people at increased cardiovascular risk. The national AHSN CVD programme will help increase the numbers of those who have their cholesterol measured, and to identify those with conditions that increase familial risk of hypercholesterolaemia.
This is to reduce: